Letrozole
Read all of this leaflet carefully before taking this medicine because it contains important information for you.
Letrozole Accord contains the active substance letrozole. Letrozole belongs to a group of medicines called aromatase inhibitors. It is a hormonal (endocrine) medicine used to treat breast cancer. The growth of breast cancer is often stimulated by estrogens, which are female sex hormones. Letrozole Accord reduces the amount of estrogen by blocking the enzyme (aromatase) involved in estrogen production and can therefore stop or slow the growth of hormone-receptor-positive breast cancer.
Letrozole Accord is used to treat breast cancer in postmenopausal women (women who have stopped menstruating).
Letrozole Accord is used to prevent the return of breast cancer. It may be used as the first treatment before breast cancer surgery if immediate surgery is not suitable or may be used as the first treatment after breast cancer surgery or after 5 years of treatment with tamoxifen.
Letrozole Accord is also used to prevent the spread of breast cancer to other parts of the body in patients with advanced disease.
If you have any questions about how Letrozole Accord works or why it has been prescribed for you, ask your doctor.
Follow the instructions of your doctor. They may differ from the general information in this leaflet.
If any of the above applies to you, do not take this medicine and tell your doctor.
Before taking Letrozole Accord, tell your doctor or pharmacist:
If any of the above applies to you, tell your doctor. Your doctor will consider this information when treating you with Letrozole Accord.
Letrozole may cause inflammation or damage (tear) to tendons (see section 4). If you experience pain or swelling in your tendons, rest the affected area and tell your doctor.
Do not give this medicine to children and adolescents.
This medicine can be given to elderly patients at the same dose as for other adults.
Tell your doctor or pharmacist about all the medicines you are taking or have recently taken, including those obtained without a prescription.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you experience dizziness, tiredness, drowsiness, or a general feeling of being unwell, do not drive or operate machinery until your condition improves.
Letrozole Accord contains lactose (a sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The usual dose is one Letrozole Accord tablet taken once a day.
Taking Letrozole Accord at the same time every day will help you remember to take your tablet.
The tablet can be taken with or without food and should be swallowed whole with a glass of water or another liquid.
Keep taking Letrozole Accord for as long as your doctor tells you to. You may need to take it for several months or even years. If you are unsure about how long to take Letrozole Accord, ask your doctor.
This medicine should always be taken under close medical supervision. Your doctor will regularly check your overall health to ensure the treatment is working properly.
Letrozole Accord may cause thinning or loss of bone density (osteoporosis) due to the reduction of estrogen levels in your body. Your doctor may order a bone density test before, during, and after treatment.
If you have taken more Letrozole Accord than you should, contact your doctor or the nearest hospital immediately. Bring the medicine pack with you.
If it is almost time for your next dose (e.g., 2 to 3 hours), skip the missed dose and take the next dose at the usual time.
In other cases, take the dose as soon as you remember and then take the next tablet at the usual time.
Do not take a double dose to make up for a forgotten tablet.
Do not stop taking Letrozole Accord unless your doctor tells you to (see also "How long to take Letrozole Accord").
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most side effects are mild or moderate and usually disappear after a few days or weeks of treatment.
Rare side effects(may affect up to 1 in 10,000 people):
Uncommon side effects(may affect up to 1 in 100 people):
Swollen and red veins (thrombophlebitis)
You should also tell your doctor immediately if you experience any of the following while taking Letrozole Accord:
Very common side effects(may affect more than 1 in 10 people)
If any of these side effects gets serious, tell your doctor.
Common side effects(may affect up to 1 in 10 people)
If any of these side effects gets serious, tell your doctor.
Uncommon side effects(may affect up to 1 in 100 people)
Frequency not known(frequency cannot be estimated from the available data)
If any of these side effects gets serious, tell your doctor.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in the "Contact details for the reporting of side effects" section below.
In the UK, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Each film-coated tablet contains 2.5 mg of letrozole.
The other ingredients are:
Tablet core: lactose monohydrate, maize starch, hypromellose 2910, sodium carboxymethylcellulose type A, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate.
Coating: hypromellose 6 cp E 464, titanium dioxide E 171, yellow iron oxide E 172, macrogol 400, and talc E 553b.
Letrozole Accord 2.5 mg film-coated tablets are yellow, round, biconvex, film-coated, and smooth on both sides.
Letrozole Accord tablets are packaged in blisters in packs containing 10, 14, 28, 30, 50, 60, 84, 90, 98, or 100 tablets.
Not all pack sizes may be marketed.
Accord Healthcare Polska Sp. z o.o.
Taśmowa 7
02-677 Warsaw
Phone: +48 22 577 28 00
Accord Healthcare Polska Sp. z o.o.
Lutomierska 50
95-200 Pabianice
Accord Healthcare B.V.
Winthontlaan 200
3526 KV Utrecht
Netherlands
Accord Healthcare Single Member S.A.
64th Km National Road Athens
32009 Lamia
Greece
Member State | Marketing Authorisation Holder |
Cyprus | Letrozole Accord 2.5 mg film-coated tablets |
Estonia | Letrozole Accord 2.5 mg film-coated tablets |
Lithuania | Letrozole Accord 2.5 mg film-coated tablets |
Malta | Letrozole 2.5mg film-coated Tablets |
Poland | Letrozole Accord |
Romania | Letrozol Accord 2.5 mg film-coated tablets |
United Kingdom (Northern Ireland) | Letrozole 2.5 mg film-coated Tablets |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.